PRESS RELEASE published on 07/15/2025 at 14:00, 1 year ago Eckert & Ziegler: Outstanding Training Quality Once Again Awarded Eckert & Ziegler SE awarded for exceptional training quality by Berlin Chamber of Industry and Commerce for the fourth consecutive time, emphasizing practical experience and career prospects for trainees Eckert & Ziegler Career Prospects Training Quality Berlin Chamber Of Industry And Commerce Trainee Team
BRIEF published on 06/18/2025 at 16:10, 1 year 1 month ago Eckert & Ziegler SE Declares EUR 0.50 Dividend at Annual General Meeting Annual General Meeting Shareholders Dividend Financial Year 2024 Eckert & Ziegler SE
BRIEF published on 06/18/2025 at 16:10, 1 year 1 month ago Eckert & Ziegler SE déclare un dividende de 0,50 € lors de son assemblée générale annuelle Actionnaires Dividende Assemblée Générale Annuelle Eckert & Ziegler SE Exercice Financier 2024
PRESS RELEASE published on 06/18/2025 at 16:05, 1 year 1 month ago Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50 Eckert & Ziegler SE's Annual General Meeting approves dividend of EUR 0.50 per share for 2024 fiscal year. Detailed voting results available online Annual General Meeting Shareholders Voting Results Dividend Eckert & Ziegler SE
BRIEF published on 06/05/2025 at 10:05, 1 year 2 months ago Eckert & Ziegler se développe avec l'approbation d'Illuccix® en Allemagne Gallium-68 Médecine Nucléaire Cancer De La Prostate Illuccix® Imagerie PSMA-PET
BRIEF published on 06/05/2025 at 10:05, 1 year 2 months ago Eckert & Ziegler Expands with Approval of Illuccix® in Germany Gallium-68 Nuclear Medicine Prostate Cancer Illuccix® PSMA-PET Imaging
PRESS RELEASE published on 06/05/2025 at 10:00, 1 year 2 months ago Eckert & Ziegler: Illuccix® PSMA-PET Imaging Agent Receives Approval in Germany Eckert & Ziegler announces the approval of Illuccix® PSMA-PET Imaging Agent in Germany, expanding its nuclear medicine portfolio and partnership with Telix Pharmaceuticals Eckert & Ziegler Germany Approval Illuccix PSMA-PET
BRIEF published on 05/30/2025 at 10:05, 1 year 2 months ago Eckert & Ziegler Hosts Successful Boston Radionuclide Theranostics Forum Precision Oncology Industry Collaboration Radiopharmaceuticals Theranostics Forum Event Insights
BRIEF published on 05/30/2025 at 10:05, 1 year 2 months ago Eckert & Ziegler organise avec succès le Boston Radionuclide Theranostics Forum Oncologie De Précision Produits Radiopharmaceutiques Collaboration Industrielle Forum Théranostique Informations Sur Les Événements
PRESS RELEASE published on 05/30/2025 at 10:00, 1 year 2 months ago Eckert & Ziegler Organizes Third Boston Radionuclide Theranostics Forum Eckert & Ziegler successfully completes the 3rd annual Boston Radionuclide Theranostics Forum, gathering key leaders to discuss radionuclides in precision oncology Innovation Eckert & Ziegler Precision Oncology Radiopharmaceuticals Boston Radionuclide Theranostics Forum
Published on 08/07/2026 at 00:45, 8 hours 10 minutes ago NXT Energy Solutions Announces Second Quarter 2026 Results
Published on 08/06/2026 at 23:15, 9 hours 40 minutes ago LNG Energy Group Announces Issuance of Second Partial Revocation Order and Further Details on Private Placement Financing
Published on 08/06/2026 at 22:15, 10 hours 40 minutes ago Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Published on 08/06/2026 at 22:05, 10 hours 50 minutes ago Innodata Reports Record Second Quarter 2026 Results
Published on 08/06/2026 at 22:00, 10 hours 55 minutes ago Gold Terra Announces Closing of Second Tranche of the C$10.8M LIFE
Published on 08/07/2026 at 08:10, 45 minutes ago EQS-Adhoc: Brenntag SE raises operating EBITDA guidance for the fiscal year 2026
Published on 08/07/2026 at 08:00, 55 minutes ago SCHWEIZER increases consolidated revenue and improves EBITDA in the first half of 2026
Published on 08/07/2026 at 07:57, 57 minutes ago Galaxy Macau and Ant Bank (Macao) Financial Services Station Launches, Driving New Growth in Tourism Consumption Through Fintech
Published on 08/07/2026 at 07:30, 1 hour 25 minutes ago AUSTRIAN POST IN H1 2026: Revenue increase despite challenging market environment; Growth in e-commerce and declining mail business
Published on 08/07/2026 at 08:30, 25 minutes ago Disclosure of shares outstanding and voting rights - 07.08.2026
Published on 08/07/2026 at 08:30, 25 minutes ago Déclaration nombre d'actions et droits de vote - 07.08.2026
Published on 08/06/2026 at 18:26, 14 hours 29 minutes ago Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 18:26, 14 hours 29 minutes ago Air Liquide droits de vote au 31 juillet 2026
Published on 08/06/2026 at 17:46, 15 hours 9 minutes ago Déclaration des droits de vote à fin juillet 2026
